Sun Pharmaceutical on Friday said court convened meeting of its shareholders has approved the scheme of amalgamation of Sun Pharma Global Inc with itself.
The scheme of amalgamation of Sun Pharma Global Inc with Sun Pharmaceutical Industries has been “approved by the equity shareholders with requisite majority,” Sun Pharma said in a filing to the BSE.
A total of 99.99 per cent votes were polled in favour of amalgamation scheme, it added.
Sun Pharma has been present in the US since 1996, working with the country’s healthcare system with a focus on generics, branded generics and over-the-counter (OTC) products.
Shares of Sun Pharmaceutical Industries were trading at Rs 857.50 per scrip in the afternoon trade on BSE, up 3.05 per cent from its previous close.
